- Home
- AMPG vs CLRB Comparison
AMPG vs CLRB Comparison
Compare AMPG & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- CLRB
- Stock Information
- Founded
- AMPG 2002
- CLRB 2002
- Country
- AMPG United States
- CLRB United States
- Employees
- AMPG N/A
- CLRB N/A
- Industry
- AMPG Telecommunications Equipment
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- CLRB Health Care
- Exchange
- AMPG Nasdaq
- CLRB Nasdaq
- Market Cap
- AMPG 11.8M
- CLRB 10.7M
- IPO Year
- AMPG N/A
- CLRB N/A
- Fundamental
- Price
- AMPG $2.11
- CLRB $0.26
- Analyst Decision
- AMPG Strong Buy
- CLRB Buy
- Analyst Count
- AMPG 1
- CLRB 2
- Target Price
- AMPG $5.00
- CLRB $28.00
- AVG Volume (30 Days)
- AMPG 14.1M
- CLRB 3.7M
- Earning Date
- AMPG 11-14-2024
- CLRB 11-18-2024
- Dividend Yield
- AMPG N/A
- CLRB N/A
- EPS Growth
- AMPG N/A
- CLRB N/A
- EPS
- AMPG N/A
- CLRB N/A
- Revenue
- AMPG $11,667,163.00
- CLRB N/A
- Revenue This Year
- AMPG N/A
- CLRB N/A
- Revenue Next Year
- AMPG $58.88
- CLRB N/A
- P/E Ratio
- AMPG N/A
- CLRB N/A
- Revenue Growth
- AMPG N/A
- CLRB N/A
- 52 Week Low
- AMPG $0.64
- CLRB $0.22
- 52 Week High
- AMPG $6.43
- CLRB $4.45
- Technical
- Relative Strength Index (RSI)
- AMPG 45.34
- CLRB 18.63
- Support Level
- AMPG $1.78
- CLRB $0.25
- Resistance Level
- AMPG $2.78
- CLRB $0.33
- Average True Range (ATR)
- AMPG 0.96
- CLRB 0.03
- MACD
- AMPG -0.35
- CLRB 0.05
- Stochastic Oscillator
- AMPG 10.63
- CLRB 3.18
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.